Medgirl131:
{| class="wikitable sortable mw-collapsible }" style="font-size: small; margin-left: auto; margin-right: auto; border: none;"
|+ class="nowrap" | Liquid error: wrong number of arguments (1 for 2)</ref>}}
|-
! # !! Age !! Sex !! Medications !! Treatment duration !! Ref !! Link
|-
| 1 || 28 years || MtF || CPA 100 mg/day, EE 100 μg/day || 5 years || Gazzeri et al. (2007) || <ref name="pmid18057351">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 2 || 48 years || MtF || CPA 100 mg/day, EE ("feminizing regimen") || 10 years || Cebula et al. (2010) || <ref name="pmid20811919">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 3 || 46 years || Female || CPA 50 mg/day, E2 ("substitutive") || 10 years || Gonçalves et al. (2010) || <ref name="pmid20053802">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 4 || 83 years || Male || CPA ≥50 mg/day || 2 years || Gil et al. (2011) || <ref name="pmid21627676">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 5 || 71 years || Male || CPA ≥50 mg/day || 3 years || Gil et al. (2011) || <ref name="pmid21627676" />
|-
| 6 || 66 years || Female || CPA ≥50 mg/day || 3 years || Gil et al. (2011) || <ref name="pmid21627676" />
|-
| 7 || 43 years || Female || CPA ≥50 mg/day || 2 years || Gil et al. (2011) || <ref name="pmid21627676" />
|-
| 8 || 35 years || MtF || CPA 100 mg/day, E2 100 μg/day patch || 4 years || Bergoglio et al. (2012) || <ref name="pmid23022362">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 9 || 60 years || MtF || CPA 50 mg/day, E2 8 mg/day oral || 10 years || Knight et al. (2013) || <ref name="KnightMcDonald2013"></ref>
|-
| 10 || 51 years || Female || CPA 15 mg/day || 30 years || Bernat et al. (2015) || <ref name="pmid26264069">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 11 || 47 years || Female || CPA 25 mg/day || 15 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 12 || 43 years || Female || CPA 50 mg/day || 12 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 13 || 39 years || Female || CPA 50 mg/day || 10 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 14 || 61 years || Female || CPA 25 mg/day || 24 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 15 || 38 years || Female || CPA 25 mg/day || 10 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 16 || 45 years || Female || CPA 50 mg/day || 20 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 17 || 53 years || Female || CPA 50 mg/day || 20 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 18 || 56 years || Female || CPA 50 mg/day || 8 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 19 || 55 years || Female || CPA 50 mg/day || 30 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 20 || 49 years || Female || CPA 50 mg/day || 20 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 21 || 49 years || Female || CPA 50 mg/day || 25 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 22 || 58 years || Female || CPA 50 mg/day || 18 years || Botella et al. (2015) || <ref name="pmid26249273">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 23 || 37 years || Female || CPA 50 mg/day || 11 years || Botella et al. (2015) || <ref name="pmid26249273" />
|-
| 24 || 42 years || Male || CPA 100 mg/day || 23 years || Sys & Kestelyn (2015) || <ref name="pmid27625949">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 25 || 45 or 46 years || MtF || CPA 10 or 100 mg/day, E2 20 mg/4 months implant || 5 years || ter Wengel et al. (2015) || <ref name="pmid26888610">Liquid error: wrong number of arguments (1 for 2)</ref><ref name="pmid29688280" />
|-
| 26 || 51 years || MtF || CPA 100 mg/day, EE 100 μg/day || 25 years || ter Wengel et al. (2015) || <ref name="pmid26888610" /><ref name="pmid29688280" />
|-
| 27 || 65 years || MtF || CPA 10 mg/day, CEEs 1.25 mg/day || 19 years || ter Wengel et al. (2015) || <ref name="pmid26888610" /><ref name="pmid29688280" />
|-
| 28 || 26 years || Female || CPA 50 mg/day || 10 years || Kalamarides & Peyre (2017) || <ref name="pmid28300711">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 29 || 43 years || Female || CPA 25 mg/day || 25 years || Kalamarides & Peyre (2017) || <ref name="pmid28300711" />
|-
| 30 || 83 years || Male || CPA 200 mg/day || 7 months || Keilani & Abada (2017) || <ref name="pmid28545357">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 31 || 41 years || MtF || CPA 50 mg/day, E2 gel 1–3 mg/day || 9 years || Mancini et al. (2018) || <ref name="pmid29105524">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 32 || 51 years || MtF || CPA 20 mg/week, E2 100 μg/day patch || 11 years || Nota et al. (2018) || <ref name="pmid29688280">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 33 || 66 years || MtF || CPA 10 mg/day || 40 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 34 || 58 years || MtF || CPA 50 mg/day, E2 100 μg/day patch || 6 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 35 || 49 years || MtF || CPA, EV 2 mg/day || 16 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 36 || 51 years || MtF || CPA 100 mg/day, EE 100 μg/day patch || 26 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 37 || 50 years || MtF || CPA 50 mg/day, E2 0.6 mg/g cream 2x/day || ~10 years || Raj et al. (2018) || <ref name="pmid29930875">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 38 || 48 years || MtF || CPA 50 mg/day, E2 1 mg/g cream 3x/day || 21 years || Raj et al. (2018) || <ref name="pmid29930875" />
|- class="sortbottom"
| colspan="9" style="width: 1px;" | '''Abbreviations:''' CPA = [[Cyproterone acetate]]. E2 = [[Estradiol (medication)|Estradiol]]. EV = [[Estradiol valerate]]. CEEs = [[Conjugated estrogen]]s. EE = [[Ethinylestradiol]]. MtF = [[Transgender woman|Male-to-female (transgender woman)]]. '''Notes:''' For the Bernat et al. (2015) cases, only one was reported to be taking an estrogen (specifically estradiol).<ref name="pmid26264069" /> Froelich et al. (2008) reported an additional 8 female cases (age 33–62 years, mean 46 years; 50 mg/day CPA; 10–20 years exposure) with multiple meningiomas.<ref name="FroelichDali-Youcef2008"></ref> Cea-Soriano et al. (2012) also reported 8 cases (4 male (≥50 mg/day, = 3.28), 4 female (2 mg/day, = 1.03)) with no individual specifics.<ref name="pmid21943794">Liquid error: wrong number of arguments (1 for 2)</ref><ref name="pmid26249273" /> Cases in association with other progestins have been reported as well.<ref name="pmid26264069" /> Deipolyi, Han, & Parsa (2010) reported a case in an MtF in association with E2 100 μg/day only.<ref name="pmid20594855">Liquid error: wrong number of arguments (1 for 2)</ref>
|}<!--
--><noinclude>
==References==
[[Category:Medication templates]]
[[Category:Templates that generate named references]]
</noinclude>
|+ class="nowrap" | Liquid error: wrong number of arguments (1 for 2)</ref>}}
|-
! # !! Age !! Sex !! Medications !! Treatment duration !! Ref !! Link
|-
| 1 || 28 years || MtF || CPA 100 mg/day, EE 100 μg/day || 5 years || Gazzeri et al. (2007) || <ref name="pmid18057351">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 2 || 48 years || MtF || CPA 100 mg/day, EE ("feminizing regimen") || 10 years || Cebula et al. (2010) || <ref name="pmid20811919">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 3 || 46 years || Female || CPA 50 mg/day, E2 ("substitutive") || 10 years || Gonçalves et al. (2010) || <ref name="pmid20053802">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 4 || 83 years || Male || CPA ≥50 mg/day || 2 years || Gil et al. (2011) || <ref name="pmid21627676">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 5 || 71 years || Male || CPA ≥50 mg/day || 3 years || Gil et al. (2011) || <ref name="pmid21627676" />
|-
| 6 || 66 years || Female || CPA ≥50 mg/day || 3 years || Gil et al. (2011) || <ref name="pmid21627676" />
|-
| 7 || 43 years || Female || CPA ≥50 mg/day || 2 years || Gil et al. (2011) || <ref name="pmid21627676" />
|-
| 8 || 35 years || MtF || CPA 100 mg/day, E2 100 μg/day patch || 4 years || Bergoglio et al. (2012) || <ref name="pmid23022362">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 9 || 60 years || MtF || CPA 50 mg/day, E2 8 mg/day oral || 10 years || Knight et al. (2013) || <ref name="KnightMcDonald2013"></ref>
|-
| 10 || 51 years || Female || CPA 15 mg/day || 30 years || Bernat et al. (2015) || <ref name="pmid26264069">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 11 || 47 years || Female || CPA 25 mg/day || 15 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 12 || 43 years || Female || CPA 50 mg/day || 12 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 13 || 39 years || Female || CPA 50 mg/day || 10 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 14 || 61 years || Female || CPA 25 mg/day || 24 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 15 || 38 years || Female || CPA 25 mg/day || 10 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 16 || 45 years || Female || CPA 50 mg/day || 20 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 17 || 53 years || Female || CPA 50 mg/day || 20 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 18 || 56 years || Female || CPA 50 mg/day || 8 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 19 || 55 years || Female || CPA 50 mg/day || 30 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 20 || 49 years || Female || CPA 50 mg/day || 20 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 21 || 49 years || Female || CPA 50 mg/day || 25 years || Bernat et al. (2015) || <ref name="pmid26264069" />
|-
| 22 || 58 years || Female || CPA 50 mg/day || 18 years || Botella et al. (2015) || <ref name="pmid26249273">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 23 || 37 years || Female || CPA 50 mg/day || 11 years || Botella et al. (2015) || <ref name="pmid26249273" />
|-
| 24 || 42 years || Male || CPA 100 mg/day || 23 years || Sys & Kestelyn (2015) || <ref name="pmid27625949">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 25 || 45 or 46 years || MtF || CPA 10 or 100 mg/day, E2 20 mg/4 months implant || 5 years || ter Wengel et al. (2015) || <ref name="pmid26888610">Liquid error: wrong number of arguments (1 for 2)</ref><ref name="pmid29688280" />
|-
| 26 || 51 years || MtF || CPA 100 mg/day, EE 100 μg/day || 25 years || ter Wengel et al. (2015) || <ref name="pmid26888610" /><ref name="pmid29688280" />
|-
| 27 || 65 years || MtF || CPA 10 mg/day, CEEs 1.25 mg/day || 19 years || ter Wengel et al. (2015) || <ref name="pmid26888610" /><ref name="pmid29688280" />
|-
| 28 || 26 years || Female || CPA 50 mg/day || 10 years || Kalamarides & Peyre (2017) || <ref name="pmid28300711">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 29 || 43 years || Female || CPA 25 mg/day || 25 years || Kalamarides & Peyre (2017) || <ref name="pmid28300711" />
|-
| 30 || 83 years || Male || CPA 200 mg/day || 7 months || Keilani & Abada (2017) || <ref name="pmid28545357">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 31 || 41 years || MtF || CPA 50 mg/day, E2 gel 1–3 mg/day || 9 years || Mancini et al. (2018) || <ref name="pmid29105524">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 32 || 51 years || MtF || CPA 20 mg/week, E2 100 μg/day patch || 11 years || Nota et al. (2018) || <ref name="pmid29688280">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 33 || 66 years || MtF || CPA 10 mg/day || 40 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 34 || 58 years || MtF || CPA 50 mg/day, E2 100 μg/day patch || 6 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 35 || 49 years || MtF || CPA, EV 2 mg/day || 16 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 36 || 51 years || MtF || CPA 100 mg/day, EE 100 μg/day patch || 26 years || Nota et al. (2018) || <ref name="pmid29688280" />
|-
| 37 || 50 years || MtF || CPA 50 mg/day, E2 0.6 mg/g cream 2x/day || ~10 years || Raj et al. (2018) || <ref name="pmid29930875">Liquid error: wrong number of arguments (1 for 2)</ref>
|-
| 38 || 48 years || MtF || CPA 50 mg/day, E2 1 mg/g cream 3x/day || 21 years || Raj et al. (2018) || <ref name="pmid29930875" />
|- class="sortbottom"
| colspan="9" style="width: 1px;" | '''Abbreviations:''' CPA = [[Cyproterone acetate]]. E2 = [[Estradiol (medication)|Estradiol]]. EV = [[Estradiol valerate]]. CEEs = [[Conjugated estrogen]]s. EE = [[Ethinylestradiol]]. MtF = [[Transgender woman|Male-to-female (transgender woman)]]. '''Notes:''' For the Bernat et al. (2015) cases, only one was reported to be taking an estrogen (specifically estradiol).<ref name="pmid26264069" /> Froelich et al. (2008) reported an additional 8 female cases (age 33–62 years, mean 46 years; 50 mg/day CPA; 10–20 years exposure) with multiple meningiomas.<ref name="FroelichDali-Youcef2008"></ref> Cea-Soriano et al. (2012) also reported 8 cases (4 male (≥50 mg/day, = 3.28), 4 female (2 mg/day, = 1.03)) with no individual specifics.<ref name="pmid21943794">Liquid error: wrong number of arguments (1 for 2)</ref><ref name="pmid26249273" /> Cases in association with other progestins have been reported as well.<ref name="pmid26264069" /> Deipolyi, Han, & Parsa (2010) reported a case in an MtF in association with E2 100 μg/day only.<ref name="pmid20594855">Liquid error: wrong number of arguments (1 for 2)</ref>
|}<!--
--><noinclude>
==References==
[[Category:Medication templates]]
[[Category:Templates that generate named references]]
</noinclude>
from Wikipedia - New pages [en] http://bit.ly/2GOF0L8
via IFTTT
No comments:
Post a Comment